Literature DB >> 9051313

Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.

N H Prins1, M R Briejer, J A Schuurkes.   

Abstract

1. Although conscious dogs have often been used for colonic motility studies with 5-hydroxytryptamine (5-HT), the effects of 5-HT on the isolated colon have not been thoroughly characterized yet. The current study was undertaken to characterize the response to 5-HT of the canine isolated colon longitudinal muscle. 2. Longitudinal strips of canine midcolon deprived of (sub)mucosa were prepared for isotonic measurement. 5-HT induced contractions from 3 nM onwards, which were not affected by selective inhibition of 5-HT re-uptake, monoamine oxidase or blockade of alpha-adrenoceptors. Tetrodotoxin (0.3 microM) did not affect the responses to 5-HT, suggesting that smooth muscle 5-HT receptors are involved. The selective 5-HT4 receptor antagonist SB 204070 (10 nM) slightly enhanced contractions to 5-HT and therefore it was included in the organ bath solution in all further experiments. The 5-HT1 and 5-HT2 receptor antagonist methysergide (0.1 microM) depressed the curve to 5-HT, but the selective 5-HT3 receptor antagonist granisetron (0.3 microM) had no effect. 3. Besides 5-HT, alpha-methyl-5-HT (alpha-Me-5-HT), 5-methoxytryptamine (5-MeOT), 2-methyl-5-HT (2-Me-5-HT) and 5-carboxamidotryptamine (5-CT) also induced contractions, with the following rank order of potency (pEC50 values in parentheses): 5-HT (6.9) = alpha-methyl-5-HT (6.9) > 2-Me-5-HT (5.8) = 5-MeOT (5.7) = 5-CT (5.6), indicative of 5-HT2 receptor involvement, alpha-Me-5-HT produced a bell-shaped curve, which was not affected by alpha-adrenoceptor blockade. 5-HT, 5-MeOT, 2-Me-5-HT and 5-CT produced a monophasic concentration-response curve, consistent with an interaction with a single receptor site. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and tryptamine only induced contractions at a concentration exceeding 1 microM. 4. The selective 5-HT2B receptor antagonist SB 204741 (0.3 microM) did not affect the curve to 5-HT. Ketanserin, cisapride and spiroxatrine behaved as competitive antagonists with pKb values of, respectively, 8.4, 8.1 and 6.7. Spiroxatrine (1 microM) shifted the curve to 5-MeOT rightward yielding an apparent pA2 of 7.1. Other antagonists at 5-HT2A receptors also surmountably inhibited the contractions to 5-HT (apparent pA2 value in parentheses): mesulergine (8.2), cinanserin (8.2), yohimbine (6.2) and mianserin (8.6). However, as well as a rightward shift, methiothepin (8.3), pizotifen (8.6) and spiperone (8.8) also caused a depression of the curve, indicative of "pseudo-irreversible' antagonism. Taken together, the above mentioned affinity estimates most closely corresponded to literature affinity values for 5-HT2A receptors. 5. It was concluded that 5-HT induces contractions of the canine midcolon longitudinal muscle primarily by stimulation of smooth muscle 5-HT2A receptors. The presence of inhibitory 5-HT4 receptors cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051313      PMCID: PMC1564512          DOI: 10.1038/sj.bjp.0700954

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle.

Authors:  N H Prins; J F Van Haselen; R A Lefebvre; M R Briejer; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Evidence that activation of central 5-HT(2B) receptors causes renal sympathoexcitation in anaesthetized rats.

Authors:  I D Knowles; A G Ramage
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

3.  Smooth muscle 5-HT2A receptors mediating contraction of porcine isolated proximal stomach strips.

Authors:  P Janssen; N H Prins; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

4.  Divergent changes to muscarinic and serotonergic signalling following colitis.

Authors:  R W Wells; M G Blennerhassett
Journal:  Gut       Date:  2005-07-13       Impact factor: 23.059

5.  Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.

Authors:  E P Bouras; M Camilleri; D D Burton; S McKinzie
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

6.  Generalized loss of inhibitory innervation reverses serotonergic inhibition into excitation in a rabbit model of TNBS-colitis.

Authors:  Inge Depoortere; Theo Thijs; Theo L Peeters
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

7.  Mechanisms involved in the loss of excitatory post-stimulus responses by inflammation.

Authors:  Inge Depoortere; Theo Thijs; Leen Thielemans; Theo L Peeters
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-19       Impact factor: 3.000

8.  5-HT7 receptor efficacy distribution throughout the canine stomach.

Authors:  Pieter Janssen; Nicolaas H Prins; Pieter J Peeters; Klaas P Zuideveld; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

9.  Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.

Authors:  Nicholas L Meyers; Roger I Hickling
Journal:  Drugs R D       Date:  2008

10.  The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.

Authors:  D T Beattie; J A M Smith; D Marquess; R G Vickery; S R Armstrong; T Pulido-Rios; J L McCullough; C Sandlund; C Richardson; N Mai; P P A Humphrey
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.